SCHEMBL1084016

SCHEMBL1084016

Cc1cc(CNc2nc(-c3ccccc3O)nc3ccc(F)cc23)no1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.50
KMT2A Q03164 10/20 0.50
RXFP1 Q9HBX9 2/20 0.50
MAPT P10636 7/20 0.48
HIF1A Q16665 2/20 0.48
ALDH1A1 P00352 5/20 0.45
MAPK1 P28482 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 3/20 0.45
HCRTR1 O43613 1/20 0.45
GAA P10253 1/20 0.45
CASP1 P29466 1/20 0.45
NPSR1 Q6W5P4 3/20 0.45
EGFR P00533 1/20 0.45
PKM P14618 1/20 0.45
CYP1A2 P05177 5/20 0.44
CYP3A4 P08684 5/20 0.44
CYP2D6 P10635 5/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP2C19 P33261 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084767 0.84 MEN1 (0.52) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084782 0.82 MEN1 (0.50) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084370 0.82 PIP4K2C (0.54) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084665 0.82 MEN1 (0.52) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084660 0.81 MEN1 (0.54) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084308 0.80 MEN1 (0.50) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084256 0.80 MEN1 (0.52) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084137 0.79 MEN1 (0.56) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084352 0.79 MEN1 (0.64) MEN1KMT2ARXFP1MAPTHIF1A
SCHEMBL1084659 0.78 MEN1 (0.51) MEN1KMT2ARXFP1MAPTHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed